Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 19.02.2026 FTGS.LN IE000YZLMXT9 25,002.00 USD 557,879.14 22.313  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 19.02.2026 GFEB.LN IE000X8M8M80 600,002.00 USD 22,559,743.33 37.599  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 19.02.2026 KNG.LN IE000SNMGYT5 350,002.00 USD 7,583,061.08 21.666  ...

LOS ANGELES--(BUSINESS WIRE)--Enphase Energy, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ENPH...

HOUSTON--(BUSINESS WIRE)--Ranger Energy Services, Inc. (NYSE:RNGR) (the “Company”) will report fourth quarter and full year 2025 financial and operating results before the market opens for trading on Thursday, March 5, 2026. Following the announcement, the Company’s management will host an earnings conference call at 10:00 a.m. Eastern time (9:00 a.m. Central time). Interested parties are invited to join the call by dialing 1-833-255-2829, or 1-412-902-6710 for international calls, (request to...

OTTAWA, Ontario--(BUSINESS WIRE)--Mitel, a global leader in business communications, and L-SPARK, Canada's leading software accelerator, announced the successful Showcase of the inaugural Mitel Unified Communications Accelerator cohort, highlighting rapid innovation and market-ready integrations achieved in just six months since the program launched in August. Program collaboration and impact The Mitel Unified Communications Accelerator, powered by L-SPARK Select, connects high-potential AI, Io...

SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) (“Palladyne AI”), a U.S.-based defense and industrial technology company delivering embodied AI-powered collaborative autonomy solutions, advanced avionics, precision-manufactured components, UAVs and advanced aerospace engineering services, today announced it will host a conference call on Thursday, March 5, 2026, at 8:00 a.m. Eastern Time to discuss its financial and operational results for its fourth quarter and ful...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to present at the upcoming 46th Annual TD Cowen Healthcare Conference in Boston. Pulse Biosciences’ Management is scheduled to present on Wednesday, March 4, 2026, at 1:10 pm ET. A live and recorded webcast of the presentation will be available on the “Events Calendar and P...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s CALQUENCE® (acalabrutinib) in combination with venetoclax has been approved in the US as the first all-oral, fixed-duration regimen for the treatment of adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). The approval by the US Food and Drug Administration (FDA) was based on positive results from the AMPLIFY Phase III trial, which were presented at the American Society of Hematology 2024 Annual Meeting and...

BOSTON--(BUSINESS WIRE)--Seaport presents new meta-analysis examining the impact of clinical trial design factors on placebo response in generalized anxiety disorder trials...